Jane Street Group, LLC Anavex Life Sciences Corp. Transaction History

Jane Street Group, LLC

$384 Billion
Q1 2025

A detailed history of Jane Street Group, LLC transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Jane Street Group, LLC holds 92,300 shares of AVXL stock, worth $718,094. This represents 0.0% of its overall portfolio holdings.

Number of Shares

92,300

Previous 92,300 -0.0%

Holding current value

$718,094

Previous $791,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$5.11 - $12.56 $216,061 - $531,061	42,282 Added 67.74%	104,697 $1.12 Million
Q3 2024 Nov 14, 2024	SELL	$4.11 - $7.04 $491,272 - $841,498	-119,531 Reduced 65.7%	62,415 $354,000
Q2 2024 Aug 14, 2024	BUY	$3.39 - $5.02 $464,585 - $687,970	137,046 Added 305.22%	181,946 $767,000
Q1 2024 May 15, 2024	SELL	$4.55 - $6.75 $306,715 - $455,017	-67,410 Reduced 60.02%	44,900 $228,000
Q4 2023 Feb 14, 2024	BUY	$5.04 - $9.95 $151,497 - $299,087	30,059 Added 36.55%	112,310 $1.05 Million
Q3 2023 Nov 14, 2023	SELL	$6.55 - $9.37 $2.31 Million - $3.3 Million	-352,041 Reduced 81.06%	82,251 $538,000
Q2 2023 Aug 14, 2023	BUY	$7.66 - $9.5 $3.17 Million - $3.93 Million	413,231 Added 1962.07%	434,292 $3.53 Million
Q1 2023 May 15, 2023	BUY	$8.32 - $11.75 $60,677 - $85,692	7,293 Added 52.97%	21,061 $180,000
Q4 2022 Feb 14, 2023	SELL	$7.65 - $14.43 $63,892 - $120,519	-8,352 Reduced 37.76%	13,768 $127,000
Q3 2022 Nov 14, 2022	BUY	$8.9 - $12.86 $27,794 - $40,161	3,123 Added 16.44%	22,120 $228,000
Q3 2022 Nov 14, 2022	BUY	$8.9 - $12.86 $27,794 - $40,161	3,123 Added 16.44%	22,120 $228,000
Q2 2022 Aug 16, 2022	SELL	$7.31 - $12.84 $532,211 - $934,829	-72,806 Reduced 79.31%	18,997 $190,000
Q1 2022 May 17, 2022	SELL	$9.74 - $17.69 $587,643 - $1.07 Million	-60,333 Reduced 39.66%	91,803 $1.13 Million
Q4 2021 Feb 15, 2022	SELL	$16.88 - $23.31 $876,966 - $1.21 Million	-51,953 Reduced 25.46%	152,136 $2.64 Million
Q3 2021 Nov 16, 2021	SELL	$16.82 - $25.75 $22,892 - $35,045	-1,361 Reduced 0.66%	204,089 $3.66 Million
Q2 2021 Aug 16, 2021	BUY	$10.16 - $28.86 $1.27 Million - $3.61 Million	124,941 Added 155.19%	205,450 $4.7 Million
Q1 2021 May 18, 2021	BUY	$5.17 - $16.13 $362,303 - $1.13 Million	70,078 Added 671.82%	80,509 $1.2 Million
Q4 2020 Feb 17, 2021	SELL	$4.01 - $7.58 $174,884 - $330,578	-43,612 Reduced 80.7%	10,431 $57,000
Q3 2020 Nov 17, 2020	BUY	$3.8 - $5.0 $205,363 - $270,215	54,043 New	54,043 $246,000
Q3 2019 Nov 14, 2019	SELL	$2.22 - $3.9 $316,014 - $555,161	-142,349 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$2.75 - $3.7 $356,600 - $479,790	129,673 Added 1022.98%	142,349 $480,000
Q1 2019 May 16, 2019	BUY	$1.68 - $3.42 $21,295 - $43,351	12,676 New	12,676 $39,000
Q3 2018 Nov 14, 2018	SELL	$2.23 - $3.82 $133,365 - $228,455	-59,805 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$2.08 - $4.26 $124,394 - $254,769	59,805 New	59,805 $157,000

Others Institutions Holding AVXL

# of Institutions

203

Shares Held

31M

Call Options Held

1.3M

Put Options Held

662K

View Full List

About ANAVEX LIFE SCIENCES CORP.

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $606M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

More about AVXL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Anavex Life Sciences Corp. Transaction History